Risk for lung cancer in workers exposed to benzidine and/or beta-naphthylamine: A protocol for systematic review and meta-analysis

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Tomioka, Kimiko ^a   Saeki, Keigo ^a   Obayashi, Kenji ^a   Tanaka, Yuu ^a   Kurumatani, Norio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Benzidine; Beta naphthylamine; Incidence; Lung cancer; Meta analysis; Mortality; Occupational exposure; Protocol; Systematic review

Indexed keywords

2 NAPHTHYLAMINE; BENZIDINE; BENZIDINE DERIVATIVE; RUBBER;

ARTICLE; CANCER RISK; EXPOSURE; HUMAN; LUNG CANCER; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY ANALYSIS; SMOKING; STANDARDIZED INCIDENCE RATIO; STANDARDIZED MORTALITY RATIO; SYSTEMATIC REVIEW; WORKER; ADVERSE EFFECTS; CHEMICAL INDUSTRY; INCIDENCE; LUNG NEOPLASMS; METHODOLOGY; OCCUPATIONAL EXPOSURE; RISK FACTOR;

2-NAPHTHYLAMINE; BENZIDINES; CHEMICAL INDUSTRY; HUMANS; INCIDENCE; LUNG NEOPLASMS; OCCUPATIONAL EXPOSURE; RESEARCH DESIGN; RISK FACTORS; RUBBER;

EID: 84928011425     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-112     Document Type: Article

References (33)

1. International Agency for Research on Cancer (IARC) Chemical agents and related occupations. A review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F Lyon: IARC 2012, 53-63.
2. International Agency for Research on Cancer (IARC) Chemical agents and related occupations. A review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F 2012, 83-92. Lyon: IARC, Iternational Agency for Research on Cancer (IARC).
3. Axtell CD, Ward EM, McCabe GP, Schulte PA, Stern FB, Glickman LT. Underlying and multiple cause mortality in a cohort of workers exposed to aromatic amines. Am J Ind Med 1998, 34:506-511. 10.1002/(SICI)1097-0274(199811)34:5<506::AID-AJIM12>3.0.CO;2-5, 9787856.
4. Bulbulyan MA, Figgs LW, Zahm SH, Savitskaya T, Goldfarb A, Astashevsky S, Zaridze D. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol 1995, 24:266-275. 10.1093/ije/24.2.266, 7635585.
5. Cassidy LD, Youk AO, Marsh GM. The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine. Am J Ind Med 2003, 44:282-290. 10.1002/ajim.10268, 12929148.
6. Morinaga K, Oshima A, Hara I. Multiple primary cancers following exposure to benzidine and beta-naphthylamine. Am J Ind Med 1982, 3:243-246. 10.1002/ajim.4700030303, 7171086.
7. Pira E, Piolatto G, Negri E, Romano C, Boffetta P, Lipworth L, McLaughlin JK, La Vecchia C. Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up. J Natl Cancer Inst 2010, 102:1096-1099. 10.1093/jnci/djq214, 20548022.
8. Rosenman KD, Reilly MJ. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers. Am J Ind Med 2004, 46:505-512. 10.1002/ajim.20093, 15490466.
9. Agency for Toxic Substances and Disease Registry Toxicological Profile for Benzidine 2001, Atlanta, GA: U.S: Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
10. Littlefield NA, Nelson CJ, Frith CH. Benzidine dihydrochloride: toxicological assessment in mice during chronic exposures. J Toxicol Environ Health 1983, 12:671-685. 10.1080/15287398309530459, 6366243.
11. Theiss JC, Shimkin MB, Weisburger EK. Pulmonary adenoma response of strain A mice to sulfonic acid derivatives of 1-and 2-naphthylamines. J Natl Cancer Inst 1981, 67:1299-1302.
12. Stoner GD, Conran PB, Greisiger EA, Stober J, Morgan M, Pereira MA. Comparison of two routes of chemical administration on the lung adenoma response in strain A/J mice. Toxicol Appl Pharmacol 1986, 82:19-31. 10.1016/0041-008X(86)90433-3, 3945940.
13. Hatch FT, Knize MG, Colvin ME. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency. Environ Mol Mutagen 2001, 38:268-291. 10.1002/em.10028, 11774358.
14. Scribner JD, Fisk SR, Scribner NK. Mechanisms of action of carcinogenic aromatic amines: an investigation using mutagenesis in bacteria. Chem Biol Interact 1979, 26:11-25. 10.1016/0009-2797(79)90090-5, 380829.
15. Jarabek AM, Pottenger LH, Andrews LS, Casciano D, Embry MR, Kim JH, Preston RJ, Reddy MV, Schoeny R, Shuker D, Skare J, Swenberg J, Williams GM, Zeiger E. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Crit Rev Toxicol 2009, 39:659-678. 10.1080/10408440903164155, 19743944.
16. Turesky RJ, Le Marchand L. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol 2001, 24:1169-1214.
17. Himmelstein MW, Boogaard PJ, Cadet J, Farmer PB, Kim JH, Martin EA, Persaud R, Shuker DE. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol 2009, 39:679-694. 10.1080/10408440903164163, 19743945.
18. Talaska G, Al Juburi AZ, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 1991, 88:5350-5354. 10.1073/pnas.88.12.5350, 51870, 2052611.
19. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1991, 1:61-66.
20. Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP, Kadlubar FF. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect 1994, 102(Suppl 6):11-16.
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012. 10.1001/jama.283.15.2008, 10789670.
22. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072.
23. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol 2. The Design and Analysis of Cohort Studies 1987, Lyon: IARC Scientific Publications.
24. Checkoway H, Pearce N, Dement JM. Design and conduct of occupational epidemiology studies: I. Design aspects of cohort studies. Am J Ind Med 1989, 15(4):363-373. 10.1002/ajim.4700150402, 2658565.
25. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 2013, International Agency for Research on Cancer: Lyon, France.
26. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 10 June 2014.
27. Alder N, Fenty J, Warren F, Sutton AJ, Rushton L, Jones DR, Abrams KR. Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. Am J Epidemiol 2006, 164(5):405-420. 10.1093/aje/kwj252, 16873420.
28. Dersimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007, 28:105-114. 10.1016/j.cct.2006.04.004, 16807131.
29. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
30. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
31. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992, 327:248-254. 10.1056/NEJM199207233270406, 1614465.
32. Thacker SB. Meta-analysis. JAMA 1988, 259:1685-1689. 10.1001/jama.1988.03720110047033, 3278147.
33. Petitti D. Meta-analysis, Decision Analysis, and Cost Effectiveness Analysis 1994, New York: Oxford University Press.